Closed ATM View - ATM2021-10
Genomics Cancer Clinical Trials Initiative National Technical Services
Show close time for other time zones
Canberra, Sydney, Melbourne, Adelaide, Perth, Brisbane, Darwin, Hobart
The Australian Government, under the Support for Cancer Clinical Trials program, is supporting Australia's capacity to develop industry-independent cancer clinical trials.
Cancer Australia is currently supporting 14 CTGs to develop industry-independent cancer clinical trial protocols to the stage of applying for grant funding.
The GCCTI National Technical Service will be required to provide, but is not limited to, the following minimum services to the CTGs supported by Cancer Australia:
- conduct workshops (minimum of one per year) including representatives from all 14 CTGs supported by Cancer Australia and other key stakeholders to identify potential molecular targets for the cancer clinical trial protocols
- develop and write, in collaboration with the CTGs, new cancer clinical trial protocols that specifically target cancer mutations and molecular markers across a range of tumour types (including performing literature reviews, reviews of international cancer mutation and molecular marker clinical trial protocols, peer review of protocols, statistical design and sample size calculations)
- develop and write, in collaboration with the CTGs, grant applications for the funding of cancer clinical trials developed (including preparation of budgets) with the aim of submitting a minimum of two competitive grant applications per year (grant applications must remain competitive and responsive to the changing requirements of competitive funders of cancer clinical trials). It is expected that several different CTGs, and other key clinicians/groups, will collaborate to conduct the clinical trials once funding has been secured.
The service provider is also required to:
- establish and maintain a multi-disciplinary Scientific Steering Group to assist in the development of clinical trial protocols
- establish collaborative relationships with other National Technical Services provided by Cancer Australia to support the CTGs.
Cancer Australia will exclude from consideration any Response that does not meet the following Mandatory Conditions for Participation:
Conditions of participation
The Tenderer must have, or be willing to maintain, if engaged, the following minimum levels of insurance and indemnity coverage (on a per claim basis) and agree to maintain it for the life of the potential contract:
a. Workers Compensation to an amount required by law
b. $10,000,000 Public Liability
c. $20,000,000 Professional Indemnity.
Minimum Content and Format Requirements
- Responses must have been approved by signature of an officer authorised to bind the company/organisation.
- Responses must be written in English; measurement must be expressed in Australian legal units of measure and any prices quoted must be in Australian dollars.
- All prices, fees and charges are to include GST (where applicable).
1 January 2022 – 30 June 2024
AusTender at www.tenders.gov.au, in accordance with instructions in Request documentation.